Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Neurology|June 3, 2011
Quantitative EEG as a predictive biomarker for Parkinson disease dementiaB T Klassen, J G Hentz, H A Shill, et al.
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Archives of Neurology|September 18, 1998
Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study GroupK D Sethi, C F O'Brien, J P Hammerstad, et al.
Parkinsonism & Related Disorders|March 10, 2007
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseJ N Caviness, J G Hentz, V G Evidente, et al.
European Journal of Neurology|November 1, 2015
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohortsJ N Caviness, R L Utianski, J G Hentz, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaM F Brin, M F Lew, C H Adler, et al.
Neurology|December 28, 2006
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystoniaJ Jankovic, C Hunter, B Z Dolimbek, et al.
Neurology|May 16, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsK Kompoliti, C H Adler, R Raman, et al.
Dementia and Geriatric Cognitive Disorders|September 14, 2007
Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's diseaseM N Sabbagh, T Lahti, D J Connor, et al.
Neurology|October 27, 1997
Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patientsR J Uitti, R E Wharen, M F Turk, et al.
Pageof 9